Semperit AG Holding, AT0000785555

Semperit AG Holding, AT0000785555

13.09.2022 - 19:03:42

EQS-Adhoc: Semperit AG Holding identifies probable impairment loss in Medical Sector in the order of approximately EUR 50 million

Disclosed inside information / Ad hoc release

Semperit identifies probable impairment loss in Medical Sector in the order of approximately EUR 50 million

?

Vienna, Austria, 13?September?2022 ? Against the backdrop of the market dynamics for examination and protective gloves, the Executive Board of Semperit AG Holding reviewed the estimates and assumptions relevant to the valuation with regard to the Medical Sector (Sempermed segment). As a result, a probable impairment loss in the order of approximately EUR 50 million as of 30 September 2022 was identified for the segment assets of Sempermed.

The exact amount of the impairment loss will be included in the third quarter business development figures and will be disclosed at the latest with the publication of the Q1-3 2022 results on 16 November 2022.

For queries, please contact:

Monika Riedel???????????????? Director Group Brand Management, ???? Corporate Spokesperson??????? +43 676 8715 8620??monika.riedel@semperitgroup.com Judit Helenyi Director Investor Relations +43 676 8715 8310judit.helenyi@semperitgroup.com

www.semperitgroup.com

www.linkedin.com/company/semperit-ag

?

13-Sep-2022 CET/CEST News transmitted by EQS Group AG. www.eqs.com

Language: English Company: Semperit AG Holding Am Belvedere 10 1100 Wien

Austria Phone: +43 1 79 777-310 Fax: +43 1 79 777-602 E-mail: judit.helenyi@semperitgroup.com Internet: www.semperitgroup.com ISIN: AT0000785555 Listed: Vienna Stock Exchange (Official Market) EQS News ID: 1441759 ? End of Announcement EQS News Service

1441759??13-Sep-2022?CET/CEST

@ dgap.de